ARCHIVES

M.D. Anderson Must Evaluate 8 Patients In Controversial Study

This article is from The Cancer Letter archive.

Vol. 22 No. 22 | May 31, 1996

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Concept To Recomplete Data Management Contract

June 29, 1984

50-Gene Set Identifies Known Types Of Breast Cancer

February 27, 2009

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

July 27, 2007

Genasense Added To Chemo Improves Responses in CLL

December 31, 2004

LeMaistre To Retire As M.D. Anderson President In 1996

August 18, 1995

In Brief: NCAB To Ponder Organ Systems Program Fate, Cancer Centers Issues, Hear Surveillance Review

January 29, 1988